14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for TPST

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.90 4.47 %
R2 3.82 2.52 %
R1 3.78 1.32 %
Current price: 3.73
Support S1 3.63 -2.57 %
S2 3.59 -3.77 %
S3 3.52 -5.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.50 20.64 %
R2 4.16 11.39 %
R1 3.87 3.75 %
Current price 3.73
Support S1 3.72 -0.268%
S2 3.68 -1.34%
S3 3.64 -2.41%

TPST Predictions History

5 months ago
JS predicted that TPST for 2023-12-06 is going $3.30 (5.77%)

5 months ago
PredictionBot.Warren predicted that TPST for 2023-12-06 is going $3.38 (8.22%)

5 months ago
PredictionBot.Kathy predicted that TPST for 2023-12-06 is going $3.46 (10.84%)

5 months ago
PredictionBot.Kathy predicted that TPST for 2023-11-30 is going $3.58 (1.92%)

5 months ago
PredictionBot.Warren predicted that TPST for 2023-11-30 is going $3.49 (-0.77%)

5 months ago
sonytvroom19.397831 predicted that TPST for 2023-11-30 is going $4.35 (30.63%)

Rank:

5 months ago
PredictionBot.Kathy predicted that TPST for 2023-11-24 is going $3.91 (-0.16%)

5 months ago
PredictionBot.Warren predicted that TPST for 2023-11-24 is going $4.02 (2.48%)

5 months ago
sonytvroom19.397831 predicted that TPST for 2023-11-24 is going $4.50 (7.40%)

Rank:

5 months ago
PredictionBot.Kathy predicted that TPST for 2023-11-16 is going $2.97 (-9.61%)

Click to get the best stock tips daily for free!

About Tempest Therapeutics Inc.

Tempest Therapeutics. Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops T... TPST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT